Brevinin-1BYa

General Information


DRACP ID  DRACP02290

Peptide Name   Brevinin-1BYa

Sequence  FLPILASLAAKFGPKLFCLVTKKC

Sequence Length  24

UniProt ID  P84111  J9RS19 

PubChem CID  Not available

Origin  Rana boylii

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HepG2 Hepatoblastoma Blastoma LC50=6 μM CytoTox 96 non-radiactive cytotoxicity assay  1 h 1
MDA-MB-231 Breast adenocarcinoma Carcinoma LC50=9 μM CellTiter-Glo Luminescent Cell Viability assay 24, 48 h 1

Hemolytic Activity  Human erythrocytes: LC50=10 μM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antifungal



Structure Information


PDB ID  6G4U  

Predicted Structure  DRACP02290

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys18<--->Cys24

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C126H206N28O27S2

Absent amino acids  DEHMNQRWY

Common amino acids  L

Mass  301976

Pl  10.35

Basic residues  4

Acidic residues  0

Hydrophobic residues  13

Net charge  4

Boman Index  2326

Hydrophobicity  107.5

Aliphatic Index  122.08

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  125

Absorbance 280nm  5.43

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21312033

Title  Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa

Doi 10.1007/s00249-011-0679-2

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_3536

DRACP is developed by Dr.Zheng's team.